Literature DB >> 24908263

Association between metabolic syndrome and osteoporotic fracture in middle-aged and elderly Chinese peoples.

Dongchen Wang1, Ning Liu, Yulei Gao, Peijia Li, Min Tian.   

Abstract

Associations between metabolic syndrome (MetS) and osteoporotic fracture have been reported. However, the epidemiological studies are not conclusive. The objective of the study was to determine whether MetS associates with osteoporotic fracture. This was a cross-sectional study of 9,930 Chinese adults aged 40 years or older in the Chongming District, Shanghai, China. A questionnaire, anthropometric measurements and laboratory tests were conducted. Metabolic syndrome was defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian Americans. A history of fractures was collected with an interviewer-assisted questionnaire. Osteoporotic fractures were defined as fractures that occurred due to low trauma in 2 years prior to the study. Among women, the prevalence of osteoporotic fractures was significantly higher in those with MetS (3.5 vs. 2.6 %, = 0.028). However, the difference was not found in men (2.6 vs. 2.4 %, P = 0.737). The presence of MetS was significantly associated with increased odds of osteoporotic fracture among women (odds ratio 1.22; 95 % confidence interval 1.12-1.54; P = 0.039) after controlling for potential confounders. The significant associations were not detected in men. The presence of MetS was significantly associated with a recent history of osteoporotic fracture in middle-aged and elderly Chinese women.

Entities:  

Mesh:

Year:  2014        PMID: 24908263     DOI: 10.1007/s12013-014-0054-x

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  7 in total

Review 1.  Does metabolic syndrome increase the risk of fracture? A systematic review and meta-analysis.

Authors:  Mazyar Babagoli; Mohammad Soleimani; Soroush Baghdadi; Mehrdad Sheikh Vatan; Seyyed Hossein Shafiei
Journal:  Arch Osteoporos       Date:  2022-08-31       Impact factor: 2.879

2.  Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?

Authors:  Janaina Da Silva Martins; João Henrique Castro; Nestor A Sainz Rueda; Luciene Machado Dos Reis; Vanda Jorgetti; Rosa Maria Affonso Moysés; Jacqueline Teixeira Caramori
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

3.  Effects of metabolic syndrome on bone mineral density, histomorphometry and remodelling markers in male rats.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Farihah Hj Suhaimi; Fairus Ahmad; Soelaiman Ima-Nirwana
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

4.  The Combined Effect of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome on Osteoporosis in Postmenopausal Females in Eastern China.

Authors:  Da-Zhi Chen; Qiao-Mai Xu; Xiao-Xin Wu; Chao Cai; Ling-Jian Zhang; Ke-Qing Shi; Hong-Ying Shi; Lan-Juan Li
Journal:  Int J Endocrinol       Date:  2018-07-29       Impact factor: 3.257

Review 5.  Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.

Authors:  Rafał Filip; Radosław P Radzki; Marek Bieńko
Journal:  Clin Interv Aging       Date:  2018-10-04       Impact factor: 4.458

6.  Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control Study.

Authors:  Kyoung Jin Kim; Jimi Choi; Ji Yoon Kim; Jae Hyun Bae; Kyeong Jin Kim; Hee Young Kim; Hye Jin Yoo; Ji A Seo; Nan Hee Kim; Kyung Mook Choi; Sei Hyun Baik; Sin Gon Kim; Nam Hoon Kim
Journal:  J Lipid Atheroscler       Date:  2021-07-06

Review 7.  The Relationship between Metabolic Syndrome and Osteoporosis: A Review.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Farihah Hj Suhaimi; Fairus Ahmad; Soelaiman Ima-Nirwana
Journal:  Nutrients       Date:  2016-06-07       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.